IP Library Granted Patent US 10,421,961
Granted Patent B2
US 10,421,961 · App. 13/377,558 · Granted Sep 24, 2019

Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells

Inventors: Chaya Brodie (Southfield, MI); Shimon Slavin (Tel-Aviv, IL)
Assignee: EXOSTEM BIOTEC LTD
C12N15/113A61K31/7105C12N5/0619C12N2310/141C12N2330/10C12N2501/13C12N2501/65C12N2506/1353C12N2510/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,421,961
App. No.
13/377,558
Granted
Sep 24, 2019
Kind
B2
Abstract

Some embodiments of the invention comprise methods, systems, and compositions to selectively induce, whether in vitro or in vivo, the neuronal differentiation of multipotent stromal cells through the application of microRNAs, including but not limited to miRNA-124, miRNA-137 and/or miRNA-9* expression products of those miRNAs, and molecules and compositions containing functional elements of those miRNAs. Some embodiments of the invention also comprise the therapeutic administration and use of such induced cells to treat mammalian injuries and diseases, including but not limited to, nervous system injuries or diseases that may otherwise result in decreased cell or system function.

Claims (9)

1. A method of trans-differentiating mammalian multipotent stromal cells into neuronal stem cells, the method comprising the steps of:

a) providing a population of mammalian multipotent stromal cells; and

b) expressing microRNA-137 in the population of mammalian multipotent stromal cells so as to generate a population of neuronal stem cells expressing nestin,

thereby trans-differentiating mammalian multipotent stromal cells into neuronal stem cells.

2. The method of claim 1 , wherein the mammal is a human.

3. The method of claim 1 , further comprising step (c) comprising analyzing a marker in said population of neuronal stem cells, wherein said marker comprises a neuronal morphology.

4. The method of claim 1 , wherein said mammalian multipotent stromal cells are derived from a tissue selected from the group consisting of adipose tissue, umbilical cord tissue, bone marrow tissue and placenta tissue.

5. The method of claim 1 , further comprising expressing in said mammalian multipotent stromal cells glial derived neurotrophic factor (GDNF).

6. The method of claim 1 , wherein said expressing comprises transfection, overexpression of exogenous miRNA or transduction of pre-miRNA.

Assignments (3)
CHANGE OF NAME Recorded Aug 12, 2019
From: BRAINSTEM BIOTEC LTD
To: EXOSTEM BIOTEC LTD
Reel/Frame 050027/0262 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2013
From: BRODIE, CHAYA
To: BRAINSTEM BIOTEC LTD.
Reel/Frame 030192/0456 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2012
From: SLAVIN, SHIMON
To: BRAINSTEM BIOTEC LTD.
Reel/Frame 028207/0277 →
Continuity (2)
Provisional Application 61185773 · Jun 10, 2009
Related Publication 20120148550A1 · Jun 14, 2012